Viral piracy: HIV-1 targets dendritic cells for transmission

Current HIV Research

Volumn 4, Issue 2, 2006, Pages 169-176

  Lekkerkerker, Annemarie N ^a   van Kooyk, Yvette ^a   Geijtenbeek, Teunis B H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C type lectins; DC SIGN; Dendritic cells; HIV 1 transmission

Indexed keywords

CD81 ANTIGEN; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; INTERCELLULAR ADHESION MOLECULE 3; LECTIN RECEPTOR; MICROBICIDE;

CD4+ T LYMPHOCYTE; CELL FUNCTION; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOID TISSUE; NONHUMAN; REVIEW; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS TRANSMISSION;

ANIMALS; ANTIGEN PRESENTATION; CELL ADHESION MOLECULES; CELL MOVEMENT; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; LECTINS, C-TYPE; MACACA; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES;

EID: 33646179354     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016206776055020     Document Type: Review

References (79)

1. Arrighi JF, Pion M, Garcia E, Escola JM, van Kooyk Y, Geijtenbeek TB, Piguet V. (2004). DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. Journal of Experimental Medicine. 200: 1279-1288.
2. Arrighi JF, Pion M, Wiznerowicz M, Geijtenbeek TB, Garcia E, Abraham S, Leuba F, Dutoit V, Ducrey-Rundquist O, van Kooyk Y, Trono D, Piguet V. (2004). Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. Journal of Virology. 78: 10848-10855.
3. Bajtay Z, Speth C, Erdei A, Dierich MP. (2004). Cutting Edge: Productive HIV-1 Infection of Dendritic Cells via Complement Receptor Type 3 (CR3, CD11b/CD18). Journal of Immunology. 173: 4775-4778.
4. Belyakov IM, Berzofsky JA. (2004). Immunobiology of Mucosal HIV Infection and the Basis for Development of a New Generation of Mucosal AIDS Vaccines. Immunity. 20: 247-253.
5. Blauvelt A. (1997). The role of skin dendritic cells in the initiation of human immunodeficiency virus infection. American Journal of Medicine. 102: 16-20.
6. Bobardt MD, Saphire AC, Hung HC, Yu X, Van der SB, Zhang Z, David G, Gallay PA. (2003). Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity. 18: 27-39.
7. Cambi A, de Lange F, van Maarseveen NM, Nijhuis M, Joosten B, van Dijk EM, de Bakker BI, Fransen JA, Bovee-Geurts PH, van Leeuwen FN, Van Hulst NF, Figdor CG. (2004). Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. Journal of Cell Biology. 164: 145-155.
8. Cameron P, Pope M, Granelli-Piperno A, Steinman RM. (1996). Dendritic cells and the replication of HIV-1. Journal of Leukocyte Biology. 59: 158-171.
9. + T cells clonal expansion. Clinical and Experimental Immunology. 88: 226-236.
10. Chougnet C, Cohen SS, Kawamura T, Landay AL, Kessler HA, Thomas E, Blauvelt A, Shearer GM. (1999). Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. Journal of Immunology. 163: 1666-1673.
11. Chow AY, Mellman I. (2005). Old lysosomes, new tricks: MHC II dynamics in DCs. Trends in Immunology. 26: 72-78.
12. Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, Dragic T. (2004). CD81 is an entry coreceptor for hepatitis C virus. Proceedings of the National Academy of Sciences. 101: 7270-7274.
13. Curtis BM, Scharnowske S, Watson AJ. (1992). Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proceedings of the National Academy of Sciences. 89: 8356-8360.
14. + T cells. Nature. 417: 95-98.
15. Earl PL, Koenig S, Moss B. (1991). Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. Journal of Virology. 65: 31-41.
16. Engering A, Geijtenbeek TB, Van Vliet SJ, Wijers M, van Liempt E, Demaurex N, Lanzavecchia A, Fransen J, Figdor CG, Piguet V, van Kooyk Y. (2002). The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. Journal of Immunology. 168: 2118-2126.
17. Engering A, Van Vliet SJ, Geijtenbeek TB, van Kooyk Y. (2002). Subset of DC-SIGN(+) dendritic cells in human blood transmits HIV-1 to T lymphocytes. Blood. 100: 1780-1786.
18. Figdor CG, van Kooyk Y, Adema GJ. (2002). C-type lectin receptors on dendritic cells and Langerhans cells. Nature Reviews Immunology. 2: 77-84.
19. Frank I, Piatak M, Jr., Stoessel H, Romani N, Bonnyay D, Lifson JD, Pope M. (2002). Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs. Journal of Virology. 76: 2936-2951.
20. Frank I, Stoiber H, Godar S, Stockinger H, Steindl F, Katinger HW, Dierich MP. (1996). Acquisition of host cell-surface-derived molecules by HIV-1. AIDS. 10: 1611-1620.
21. Gallay P. (2004). Syndecans and HIV-1 pathogenesis. Microbes and Infection. 6: 617-622.
22. Garcia E, Pion M, Pelchen-Matthews A, Collinson L, Arrighi JF, Blot G, Leuba F, Escola JM, Demaurex N, Marsh M, Piguet V. (2005). HIV-1 Trafficking to the Dendritic Cell-T-Cell Infectious Synapse Uses a Pathway of Tetraspanin Sorting to the Immunological Synapse. Traffic. 6: 488-501.
23. Geijtenbeek TB, Engering A, van Kooyk Y. (2002). DC-SIGN, a C-type lectin on dendritic cells that unveils many aspects of dendritic cell biology. Journal of Leukocyte Biology. 71: 921-931.
24. Geijtenbeek TB, Kwon DS, Torensma R, Van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y. (2000). DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 100: 587-597.
25. Geijtenbeek TB, van Kooyk Y. (2003). DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission. Current Topics in Microbiology and Inummology. 276: 31-54.
26. Geijtenbeek TB, Van Vliet SJ, Engering A, 't Hart BA, van Kooyk Y. (2004). Self- and nonself-recognition by C-type lectins on dendritic cells. Annual Review of Immunology. 22: 33-54.
27. Granelli-Piperno A, Moser B, Pope M, Chen D, Wei Y, Isdell F, O'Doherty U, Paxton W, Koup R, Mojsov S, Bhardwaj N, Clark-Lewis I, Baggiolini M, Steinman RM. (1996). Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. Journal of Experimental Medicine. 184: 2433-2438.
28. Granelli-Piperno A, Pritsker A, Pack M, Shimeliovich I, Arrighi JF, Park CG, Trumpfheller C, Piguet V, Moran TM, Steinman RM. (2005). Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Nonintegrin/ CD209 Is Abundant on Macrophages in the Normal Human Lymph Node and Is Not Required for Dendritic Cell Stimulation of the Mixed Leukocyte Reaction. Journal of Immunology. 175:4265-4273.
29. Gummuluru S, Rogel M, Stamatatos L, Emerman M. (2003). Binding of human immunodeficiency virus type 1 to immature dendritic; cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. Journal of Virology. 77: 12865-12874.
30. Gurney KB, Elliott J, Nassanian H, Song C, Soilleux E, McGowan I, Anton PA, Lee B. (2005). Binding and Transfer of Human Immunodeficiency Virus by DC-SIGN+ Cells in Human Rectal Mucosa. Journal of Virology. 79: 5762-5773.
31. Hemler ME. (2005). Tetraspanin function and associated microdomains. Nature Reviews Molecular Cell Biology. 6: 801-811.
32. Hu J, Gardner MB, Miller CJ. (2000). Simian Immunodeficiency Virus Rapidly Penetrates the Cervicovaginal Mucosa after Intravaginal Inoculation and Infects Intraepithelial Dendritic Cells. Journal of Virology. 74: 6087-6095.
33. Hu Q, Frank I, Williams V, Santos JJ, Watts P, Griffin GE, Moore JP, Pope M, Shattock RJ. (2004). Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. Journal of Experimental Medicine. 199: 1065-1075.
34. Kacani L, Frank I, Spruth M, Schwendinger MG, Mullauer B, Sprinzl GM, Steindl F, Dierich MP. (1998). Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages. Journal of Virology. 72: 6671-6677.
35. Kawamura T, Gulden FO, Sugaya M, McNamara DT, Borris DL, Lederman MM, Orenstein JM, Zimmerman PA, Blauvelt A. (2003). R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proceedings of the National Academy of Sciences. 100: 8401-8406.
36. Kwon DS, Gregorio G, Bitton N, Hendrickson WA, Littman DR. (2002). DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity. 16: 135-144.
37. Lederman MM, Veazey RS, Offord R, Mosier DE, Dufour J, Mefford M, Piatak M, Jr., Lifson JD, Salkowitz JR, Rodriguez B, Blauvelt A, Hartley O. (2004). Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5. Science. 306: 485-487.
38. Lee B, Leslie G, Soilleux E, O'Doherty U, Baik S, Levroney E, Flummerfelt K, Swiggard W, Coleman N, Malim M, Doms RW. (2001). cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. Journal of Virology. 75: 12028-12038.
39. Lekkerkerker AN, Ludwig IS, Van Vliet SJ, van Kooyk Y, Geijtenbeek TB. (2004). Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120. Virology. 329: 465-476.
40. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ. (1990). Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. Journal of Biological Chemistry. 265: 10373-10382.
41. Liu YJ. (2001). Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 106: 259-262.
42. + T cells. Journal of Experimental Medicine. 201: 2023-2033.
43. Lu W, Arraes LC, Ferreira WT, Andrieu JM. (2004). Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nature Medicine. 10: 1359-1365.
44. Ludwig IS, Lekkerkerker AN, Depla E, Bosman F, Musters RJ, Depraetere S, van Kooyk Y, Geijtenbeek TB. (2004). Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. Journal of Virology. 78: 8322-8332.
45. Lue J, Hsu M, Yang D, Marx P, Chen Z, Cheng-Mayer C. (2002). Addition of a Single gp120 Glycan Confers Increased Binding to Dendritic Cell-Specific ICAM-3-Grabbing Nonintegrin and Neutralization Escape to Human Immunodeficiency Virus Type 1. Journal of Virology. 76: 10299-10306.
46. Manes S, del Real G, Martinez A. (2003). Pathogens: raft hijackers. Nat Rev Inummol. 3: 557-568.
47. McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, Hope TJ. (2003). Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science. 300: 1295-1297.
48. Mitchell DA, Fadden AJ, Drickamer K. (2001). A novel mechanism of carbohydrate recognition by the C-type lectins DC- SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. Journal of Biological Chemistry. 276: 28939-28945.
49. Mizuochi T, Matthews TJ, Kato M, Hamako J, Titani K, Solomon J, Feizi T. (1990). Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. Journal of Biological Chemistry. 265: 8519-8524.
50. Moris A, Nobile C, Buseyne F, Porrot F, Abastado JP, Schwartz O. (2004). DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood. 103: 2648-2654.
51. Nguyen DG, Hildreth JE. (2003). Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. European Journal of Immunology. 33: 483-493.
52. Nguyen DG, Booth A, Gould SJ, Hildreth JEK. (2003). Evidence That HIV Budding in Primary Macrophages Occurs through the Exosome Release Pathway. Journal of Biological Chemistry. 278: 52347-52354.
53. Nijman HW, Kleijmeer MJ, Ossevoort MA, Oorschot VM, Vierboom MP, van de KM, Kenemans P, Kast WM, Geuze HJ, Melief CJ. (1995). Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. Journal of Experimental Medicine. 182: 163-174.
54. Nobile C, Petit C, Moris A, Skrabal K, Abastado JP, Mammano F, Schwartz O. (2005). Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. Journal of Virology. 79: 5386-5399.
55. Ono A, Freed EO. (2004). Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. Journal of Virology. 78: 1552-1563.
56. Ouellet M, Mercier S, Pelletier I, Bounou S, Roy J, Hirabayashi J, Sato S, Tremblay MJ. (2005). Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to ho st cells. Journal of Immunology. 174: 4120-4126.
57. Piguet V, Sattentau Q. (2004). Dangerous liaisons at the virological synapse. Journal of Clinical Investigation. 114: 605-610.
58. Pohlmann S, Leslie GJ, Edwards TG, Macfarlan T, Reeves JD, Hiebenthal-Millow K, Kirchhoff F, Baribaud F, Donis RW. (2001). DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions. Journal of Virology. 75: 10523-10526.
59. Pohlmann S, Baribaud F, Lee B, Leslie GJ, Sanchez MD, Hiebenthal-Millow K, Munch J, Kirchhoff F, Donis RW. (2001). DC-SIGN Interactions with Human Immunodeficiency Virus Type 1 and 2 and Simian Immunodeficiency Virus. Journal of Virology. 75: 4664-4672.
60. Pope M, Haase AT. (2003). Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nature Medicine. 9: 847-852.
61. Sattentau. QJ, Moore JP, Vignaux F, Traincard F, Poignard P. (1993). Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. Journal of Virology. 67: 7383-7393.
62. Shattock RJ, Moore JP. (2003). inhibiting sexual transmission of HIV-1 infection. Nature Reviews Microbiology. 1: 25-34.
63. Snyder GA, Ford J, Torabi-Parizi P, Arthos JA, Schuck P, Colonna M, Sun PD. (2005). Characterization of DC-SIGN/R Interaction with Human Immunodeficiency Virus Type 1 gp120 and ICAM Molecules Favors the Receptor's Role as an Antigen-Capturing Rather than an Adhesion Receptor. Journal of Virology. 79: 4589-4598.
64. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, Ho DD. (1996). Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. Journal of Experimental Medicine. 183: 215-225.
65. Steinman RM. (2001). Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mount Sinai Journal of Medicine. 68: 160-166.
66. Steinman RM, Cohn ZA. (1973). Identification of a novel cell type in peripheral lymphoid organs of mice. 1. Morphology, quantitation, tissue distribution. Journal of Experimental Medicine. 137: 1142-1162.
67. Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G. (2002). The biogenesis and functions of exosomes. Traffic. 3: 321-330.
68. Trumpfheller C, Park CG, Finke J, Steinman RM, Granelli-Piperno A. (2003). Cell type-dependent retention and transmission of HTV-1 by DC-SIGN. International Immunology. 15: 289-298.
69. Turley SJ, Inaba K, Garrett WS, Ebersold M, Unternaehrer J, Steinman RM, Mellman I. (2000). Transport of peptide-MHC class II complexes in developing. dendritic cells. Science. 288: 522-527.
70. Turville S, Wilkinson J, Cameron P, Dable J, Cunningham AL. (2003). The role of dendritic cell C-type lectin receptors in HIV pathogenesis. Journal of Leukocyte Biology. 74: 710-718.
71. Turville SG, Cameron PU, Handley A, Lin G, Pohlmann S, Doms RW, Cunningham AL. (2002). Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunology. 3: 975-983.
72. Turville SG, Santos JJ, Frank I, Cameron PU, Wilkinson J, Miranda-Saksena M, Dable J, Stossel H, Romani N, Piatak M, Jr., Lifson JD, Pope M, Cunningham AL. (2004). Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood. 103: 2170-2179.
73. van Gisbergen KPJM, Paessens LC, Geijtenbeek TBH, van Kooyk Y. (2005). Molecular mechanisms that set the stage for DC-T cell engagement. Immunology Letters. 97: 199-208.
74. VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D. (2005). Antimicrobial Peptides from Amphibian Skin Potently Inhibit Human Immunodeficiency Virus Infection and Transfer of Virus from Dendritic Cells to T Cells. Journal of Virology. 79: 11598-11606.
75. Vanham G, Penne L, Allemeersch H, Kestens L, Willems B, van der GG, Jeang KT, Toossi Z, Rich E. (2000). Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. AIDS. 14: 2299-2311.
76. Vives RR, Imberty A, Sattentau QJ, Lortat-Jacob H. (2005). Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site. Journal of Biological Chemistry. 280: 21353-21357.
77. Wu L, Martin TD, Vazeux R, Unutmaz D, KewalRamani VN. (2002). Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. Journal of Virology. 76: 5905-5914.
78. Zhu X, Borchers C, Bienstock RJ, Tomer KB. (2000). Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry. 39: 11194-11204.
79. Zuckerman RA, Whittington WL, Celum CL, Collis TK, Lucchetti AJ, Sanchez JL, Hughes JP, Sanchez JL, Coombs RW. (2004). Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy. Journal of Infectious Diseases. 190: 156-161.